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INTRODUCTION
In vertebrates, glucuronidation is an important detoxification and metabolic pathway for many endogenous compounds like bile acids, bilirubin and steroid hormones, and for xenobiotics including many drugs. Glucuronidation, catalyzed by a family of UDP-glucuronosyltransferases (UGTs, EC 2.4.1.17), increases the solubility of these compounds in water so that they are much more easily excreted from the body via bile or urine. The glucuronic acid moiety is donated by the co-substrate UDP-glucuronic acid (UDPGA) and is conjugated to the aglycone substrate acceptor at a functional group, mostly hydroxyl, amino or carboxyl groups. This process leads to the formation of β-D-glucuronides of the aglycones and, in most but not all cases, also abolishes their biological activity (Fisher, et al., 2001; Ouzzine, et al., 2003; Radominska-Pandya, et al., 1999; Tukey and Strassburg, 2000) . Most UGTs can glucuronidate several substrates, often structurally unrelated, whereas one compound may be glucuronidated by several UGTs (Mackenzie, et al., 2000) .
UGTs are 529 to 534 amino acids in length, including an N-terminal signal sequence of about 25 residues that directs the nascent proteins to the endoplasmic reticulum (ER) and is later cleaved off (Kurkela, et al., 2003) . They are ER membrane proteins and are oriented such that the Nterminus and most of the protein mass are located in the lumen. There is a single trans-membrane segment close to the C-terminus and the last 20-25 C-terminal residues are on the cytoplasmic side of the endoplasmic reticulum membrane (Radominska-Pandya, et al., 1999) . Many UGTs are expressed in the liver, the major site of glucuronidation, but a few are solely extrahepatic and most human UGTs are expressed in more than one tissue (Tukey and Strassburg, 2001 ). The 19 human UGTs can be divided into two major families, UGT1 and UGT2, based on sequence similarities and gene organization (Mackenzie, et al., 1997) .
This article has not been copyedited and formatted. The final version may differ from this version. UGTs all contain two large and almost equally sized domains, the N-terminal and C-terminal halves (Radominska-Pandya, et al., 1999) . In the UGT1 subfamily, each isozyme has a variable N-terminal half encoded by different exons 1, whereas the C-terminal half is encoded by the shared exons 2 to 5 and so is identical (Ritter, et al., 1992) . The UGT2 proteins, with the exception of UGT2A1 and UGT2A2, are mostly encoded by separate genes (Mackenzie, et al., 2005) . Nonetheless, the C-terminal halves have about 60% identity with respect to the UGT1 proteins (not shown). The very high sequence conservation in the C-terminal domain immediately suggests that it binds UDPGA, the co-substrate that is used by all the UGTs.
Consequently, the aglycone substrate is believed to bind within the more variable N-terminal domain of the UGTs (Mackenzie, 1990) .
To date there is no crystal structure of any UDP-glucuronosyltransferase. UGTs belong to the superfamily of glycosyltransferases (GT) and so far all the known structures of different members of this huge protein family have been found to adopt either the 'GT-A' or 'GT-B' folds (Bourne and Henrissat, 2001 ). The GT-B fold, to which the UGTs belong, consists of two rather similar Rossman fold domains separated by a linker region. This kind of fold was originally observed in the phage T4 β -glucosyltransferase (Vrielink, et al., 1994) . In the GT-B fold, the Nterminal domain binds the acceptor and the C-terminal binds the nucleotide-sugar (Bourne and Henrissat, 2001) . Based on amino acid sequence similarity (Campbell, et al., 1997 ) (available at http://afmb.cnrs-mrs.fr/CAZY/), UGTs belong to the GT1 family in the GT-B fold. Thus far nine structures of GT1 family members are available of five different enzymes: the bacterial glycosyltransferases TDP-epi-vancosaminyltransferase GtfA, UDP-glucosyltransferase GtfB and vancosaminyltransferase GtfD, all involved in vancomycin synthesis (Mulichak, et al., 2001; Mulichak, et al., 2003; Mulichak, et al., 2004) and two plant glucosyltransferases, a triterpene/flavonoid glucosyltransferase (UGT71G1) and a flavonoid glucosyltransferase (VvGT) ((Offen, et al., 2006; Shao, et al., 2005) . The level of sequence identity between each of these 5
This article has not been copyedited and formatted. The final version may differ from this version. GTs and any of the human UGTs is unfortunately below 20%, making it difficult to model a complete UGT. Nevertheless, there is a higher degree of identity within particular conserved regions, like the nucleotide-sugar binding site.
It is presently unknown which residues within the UGTs are directly involved in either UDPGA or aglycone binding. Photoaffinity labeling experiments suggest that the UDPGA binding site is located between amino acids 299 and 466 (Battaglia, et al., 1998) . In addition, there is a conserved, characteristic motif (Prosite PS00375) that can be used to identify distant homologues. The motif, located approximately between amino acids 369 and 407 in the Cterminal half of the UGTs, may function in UDPGA binding (Tukey and Strassburg, 2001) . A much more specific suggestion was made about the role of one residue within this rather large segment. Based on mutation studies and protein modification with the reagent diethyl pyrocarbonate (DEPC), His371 (UGT1A6 numbering, sometimes inaccurately referred to as His370, probably due to the presence of one UGT1A6 sequence in the genebank that is short by one residue) was suggested to function as a catalytic base (Ouzzine, et al., 2000) .
Following on our earlier work (e.g. (Kurkela, et al., 2007) , we were looking for a poorly active mutant of UGT1A9 for functional oligomerization studies and decided to mutate the "catalytic His" in UGT1A9 to Ala, based on this suggestion (Ouzzine, et al., 2000) . We expected that the equivalent UGT1A9 mutant, 9H369A, would have very low activity. However, the mutation had much a milder effect on scopoletin (7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one) glucuronidation than expected. We therefore re-examined the role of this strictly conserved His371 using mutagenesis, kinetic analyses and modeling. We also examined the role of another highly conserved residue, Glu379 (UGT1A6 numbering). Our results suggest that, rather than being the previously proposed "catalytic residue", His371 plays an important role in UDPGA binding. The same also appears to be true for Glu379.
This article has not been copyedited and formatted. The final version may differ from this version. 
MATERIALS AND METHODS
Recombinant enzyme preparation
Recombinant control UGTs, UGT1A6 and UGT1A9, were expressed as C-terminal His-tagged fusion proteins in baculovirus-infected insect cells and membranes were isolated and stored as previously described (Kurkela, et al., 2003) . Point mutations were done by PCR, and the sequence of the entire DNA fragment that underwent PCR was verified by DNA sequencing.
Mutant UGTs, 6H371A, 6E379A, 9H369A or 9E377A were expressed and produced as the control enzymes (A prefix of '6' indicates a UGT1A6 mutant; a prefix of '9' a UGT1A9 mutant).
Preparation of the control UGTs was optimized to achieve high normalized activity (activity/expression level) rather than specific activity (avctivity/protein amount). We have not observed stability differences between the control and the mutants studied here.
Normalization
The relative expression level of each recombinant UGT, either mutant or control, was determined by immuno-detection on dot-blot using the monoclonal anti-His-tag IgG Tetra His (Qiagen) as previously described (Kurkela, et al., 2004; Kurkela, et al., 2007) . In brief, at least three replicates of each recombinant UGT membrane were made and blotted with the monoclonal antibody. The expression level of non-mutated UGT control membranes was set to one and the mutant expression levels were calculated relative to that. All the activity measurements were corrected by these relative expression levels (Fig. 1) . The expression levels varied by less than a factor of three, except for 9H369A.
HPLC activity measurements
Scopoletin, 4-methylumbelliferone, umbelliferone (7-Hydroxy-2H-1-Benzopyran-2-One) and 1-naphthol were purchased from Sigma and UDPGA triammonium salt from Fluka. Activity assay measurements with at least three replicates were made in 100 µl reactions containing 50 mM phosphate buffer pH 7.4, 10 mM MgCl 2 , 5 mM saccharolactone and 0.036-1.0 mg/ml ( 
Kinetic measurements
Kinetic measurements were done using at least eight substrate concentrations. The protein concentrations in the assays were adjusted so that no more than 10% of the substrate was used during the glucuronidation reaction. 10-4000 µM scopoletin, 1-200 µM 1-naphthol or 10-1500 µM 4-MU with either 5 or 20 mM of UDPGA was used in the measurement of the aglycone kinetics, whereas the kinetics with respect to UDPGA was done in the presence of 2 mM scopoletin and 25-20000 µM UDPGA. To obtain kinetic constants, we fit the experimental data to the Michaelis-Menten equation by nonlinear regression using GraphPad Prism. Two-substrate kinetics was done with eight UDPGA and seven scopoletin concentrations. Data from bisubstrate kinetics were fitted to equation (1) taken from Luukkanen et al. (2005) :
( 1) where V max is the maximum velocity of the reaction, K d(UDPGA) is the dissociation constant for the enzyme-UDPGA complex, K m(AGLY) and K m(UDPGA) are Michaelis constants for aglycone and UDPGA. This equation is derived from the compulsory ordered bi bi mechanism ( Fig. 2) assuming steady-state conditions. Up to three replicates were used in kinetic measurements.
Modelling
We built a model of the UGT1A6 C-terminal domain residues 288-447 using the Homology module in InsightII. We used the following structures as templates: the triterpene/flavonoid glcyosyltransferase (UGT71G1) from the legume Medicago truncatula, (PDB entry 2ACV with UDP and 2ACW with UDP-glucose) (Shao, et al., 2005) and the UPD-glucose:flavonoid 3-Oglycosyltransferase from red grape (Vitis vinifera) (VvGT) (PDB entry 2C1X with UDP, 2C1Z
with UDP-2-deoxy-2-fluoro glucose and 2C9Z with UDP and quercetin) (Offen, et al., 2006) . This article has not been copyedited and formatted. The final version may differ from this version. We initially aligned the sequences using ClustalW (http://www.ebi.ac.uk/clustalw/) and manually modified them using the information from the Jpred secondary structure prediction (http://www.compbio.dundee.ac.uk/~www-jpred/), and 3D-pssm (http://www.sbg. bio.ic.ac.uk/ 3dpssm/) and 3d-jigsaw (http://www.bmm.icnet.uk/~3djigsaw/) fold servers. The sequence identity was 21.5% to UGT71G1 and 24.7% to VvGT over the entire modelled region.
Minimization was done in InsightII using the Amber force field and steepest descent and conjugate gradient minimizations. UDPGA was docked manually to the partial model of the UGT1A6 C-terminal domain.
RESULTS
Originally we prepared the 9H369A mutant for functional oligomerization studies, expressed it in baculovirus-infected insect cells and examined its activity with scopoletin ( Fig. 3) as the aglycone substrate. The normalized glucuronidation of scopoletin by the mutant, about 40% of the control UGT1A9 under the assay conditions, was much higher then expected, assuming that this His369 residue functions as a catalytic residue in all the UGTs (Fig. 4) . Previous studies of the activity of the 6H371A mutant were performed using only 4-MU (Fig. 3) as the aglycone substrate (Ouzzine, et al., 2000) . The same substrate was therefore tested with UGT1A9 and the 9H369A mutant, revealing that the effect of this mutation is substrate-dependent (Fig. 4) . These findings prompted us to re-examine the suggested role of this strictly conserved His residue in UGT1A9, as well as in UGT1A6, the isoenzyme that was mutated in the original studies (Ouzzine, et al., 2000) .
We therefore made the corresponding mutant in UGT1A6, 6H371A. When its activity was screened with three different aglycones (Fig. 3) , it seemed that the mutation had a much more drastic effect on UGT1A6 (Fig. 5 ) than on UGT1A9 (Fig. 4) . In both isoenzymes, however, the This article has not been copyedited and formatted. The final version may differ from this version. activities for scopoletin were much higher than for 4-MU (Figs. 4 and 5) , and, even though the activities of 6H371A with scopoletin and 1-naphthol were low, they were nonetheless reduced by a factor of 30 or less. A key catalytic residue would be expected to lower the activity by a factor of 100 at least.
The realization that His371 may not be the catalytic His prompted us to investigate the effect of a mutation of another highly conserved residue in its vicinity, Glu379. This residue, strictly conserved among the human UGTs, was mutated to Ala in both UGT1A6 and UGT1A9, yielding the 6E379A and 9E377A mutants. Similarly to the H(369/371)A mutants, both E(377/379)A mutants exhibited very low 4-MU glucuronidation activity (Figs. 4 and 5). However, the scopoletin glucuronidation activity of the 9E377A mutant was almost 90% of the corresponding activity in the control UGT1A9 (Fig. 4) . Even in UGT1A6, where the mutation appears to affect activity more, the activity of the 6E379A mutant, particularly towards 1-naphthol, was higher than the corresponding activity of the 6H371A mutant (Fig. 5) . When the two isoenzymes are compared, it is clear that both mutations had a very similar and dramatic effect on glucuronidation activity for all three substrates in UGT1A6 (Fig. 5) , while the effects varied in UGT1A9 (Fig. 4) We continued to reinvestigate the role of both His371 and Glu379 in UGTs by kinetic analyses, starting with UGT1A9. The K m values were highly affected (Table 1 ) and so we could not determine reliable V max for the 9E377A mutant, although it appeared to be more active than control (data not shown). The 4 mM scopoletin (close to the solubility limit) and 20 mM UDPGA concentrations we used were still far from saturating conditions. The changes were not so dramatic for the UGT1A6 mutants, so we decided to focus on UGT1A6. The results indicated that both mutations increased the K m for aglycone substrates substantially ( Table 2 ). The K m for the co-substrate, UDPGA, increased much more than the K m for the aglycones (Table 2A and B).
The same was also true for the full bisubstrate kinetic analysis for the control and for the mutants This article has not been copyedited and formatted. The final version may differ from this version. 6H371A and 6E379A (Table 2C , Fig. 6 ). The dissociation constant K d(UDPGA) increased about 9-fold in the H371A mutant and over 30-fold in the E379A mutant, indicating severely impaired UDPGA binding (Table 2C ). The mutations have a bigger effect on UDPGA than on the aglycone binding, particularly for the E379A mutant.
To obtain further insight into the UDPGA binding site of the UGTs, we modeled the C-terminal domain of UGT1A6 up to the membrane anchor. A structural model for the C-terminal UDPGA binding site of UGT1A6 was built using InsightII and the structures of UGT71G1 and VvGT, two GT1 superfamily plant homologues, as templates (Shao, et al., 2005 ) (Offen, et al., 2006 )(see Methods). Both these glycosyltransferases catalyze the addition of glucose from UDP-glucose to acceptor molecules such as saponin (UGT71G1) or cyanidin (VvGT) (Shao, et al., 2005 ) (Offen, et al., 2006 . Hence, these two plant enzymes catalyze a similar kind of reaction to human UGTs, but they employ UDP-glucose, not UDP-glucuronic acid. The sequence around His371 is quite conserved in the GT1 superfamily, and the percentage identity of the UGT1A6 sequence to the template structures is higher in this region than over the entire C-terminal domain (Fig. 7) , thus increasing the reliability of our model. The model was minimized in InsightII using the Amber force field. The overall structural geometry was good according to Procheck analysis (Laskowski, et al., 1993) . UDP-glucose adopts the same conformation in both UGT71G1 and
VvGT, and so UDPGA was manually docked into the model in the same conformation as the UDP-glucose in VvGT.
In our model (Fig. 8) , His371 hydrogen bonds to the β -phosphate group of UDPGA and thus the model supports the suggestion that His371 of UGT1A6 is directly involved in UDPGA binding.
The model also suggests that Glu379 forms hydrogen bonds to the ribose ring. However the reason that the mutations lead to changes in substrate specificity is currently unclear. For instance, the main difference between the E A and the H A mutants, particularly for This article has not been copyedited and formatted. The final version may differ from this version. UGT1A9, was that the 9E377A mutation appeared to lower the scopoletin glucuronidation rate at most only slightly, leading to an even larger substrate-dependence of its effect than for 9H369A (Fig. 4) . Nonetheless, there is good agreement between the model and our experimental results, thus strengthening the inferences we draw below.
What can be concluded from the results? We confirmed earlier results (Ouzzine, et al., 2000) , that the 6H371A mutant has very low 4-MU activity. This naively would suggest that H371A is a catalytic residue. However, the fact that 9H369A has 40% of the activity of the control UGT1A9 with scopoletin ( Fig. 4) clearly indicated that this is not the case. Mutation of a key catalytic residue should have a much more severe impact on V max with all substrates and for both isoenzymes tested.
DISCUSSION
Much is currently known about the gene structure and different genetic elements that affect the expression of different human UGTs in our tissues. However, with respect to the structure of the UGTs, all we know is that there are two domains, a C-terminal transmembrane helix and that the overall fold they adopt is 'GT-B' (see http://afmb.cnrs-mrs.fr/CAZY/) (Campbell, et al., 1997) .
Studies on the roles of individual residues have yielded little detailed information. It was thus regarded as a major development when a specific residue, His371 in UGT1A6 (then assumed to be His370), was reported to serve as the general base by Ouzzine and coworkers (Ouzzine, et al., 2000) . In their model, His371 deprotonates the nucleophilic group on the aglycone, which then attacks the UDPGA, with subsequent release of the UDP-group. The conclusion was based on site-directed mutagenesis, 4-MU glucuronidation activity of the UGT1A6 mutants and on the interpretation of chemical modification studies, taken to indicate the presence of a "catalytic His"
in the UGTs (Ouzzine, et al., 2000 ) (Ouzzine, et al., 2003 Glu379 are in contact with the aglycone, but are involved in UDPGA binding. His371 can not be a general base, nor Glu379 a general acid.
The kinetic analyses revealed that changing either His371 or Glu379 to Ala clearly increases the K m values for three different aglycones (Tables 1 and 2 ). Why should this be so if both residues play important roles in UDPGA binding? The answer is that both mutations increase the K m values for UDPGA significantly more than they increase the aglycone K m values. Moreover, we have recently suggested that the UGTs, at least those of UGT1 subfamily, bind the two substrates sequentially with UDPGA binding first (Luukkanen, et al., 2005) . If so, the effect of either H371A or E379A mutations on the K m for the different aglycone substrates is "secondary"; the "primary" effect is on the K m for UDPGA. The mutation affects how UDPGA binds, and thus affects aglycone binding (see below).
In UGT1A9, the K m value for both UDPGA and aglycone increased suggesting that substrate binding is impaired. However, V max doubled for 9H369A (Table 2 ) and also appeared to increase substantially for 9HE377A, though the increase in K m for this mutant meant that we could not determine the value reliably (data not shown). One possible explanation is that the reduction in UDPGA binding affinity allows aglycone to bind in a catalytically more productive manner, thus reducing the effect of the substrate inhibition typically observed in UGTs (Luukkanen, et al., 2005) . The existence of such an effect is consistent with the changes we see in UGT1A6 (see above), and is not consistent with either His371 or Glu377 having a key catalytic role.
His-tag antibody detection cannot differentiate between properly folded and misfolded protein.
Could, therefore, the changes in activity we observe (see above) be due to differences in the proportion of active protein in the control and mutant preparations? The answer to this is clearly differences in the mutant responses to various substrates. The only thing that might be affect is V max . Nonetheless, we maximise the specific activity of the control UGTs during protein preparation; the relative amount of the active control enzyme is thus as high as possible.
Furthermore, we have not detected any stability differences between the control and the mutants studied here and, if the mutants were less stable, their real V max would be higher than the one we have measured (Figs. 4 and 5) -i.e. in most cases more similar to control. Finally, any differences between the activity UGT1A6 and UGT1A9 toward different substrates upon mutation are independent of the ratio of active enzyme, as that ratio does not change from substrate to substrate (Figs. 4 and 5).
The central role of His371 in UDPGA binding is supported by its conservation over a wide range of different glycosyltransferases, including GtfA (His293) and GtfD (His309), where it makes contacts with the β -phosphate in the TDP sugar donor (Mulichak, et al., 2003; Mulichak, et al., 2004) . Interestingly, in the bacterial UDP-N-acetylglucosaminyltransferase MurG, which has the GT-B fold but does not belong to the same class, the equivalent residue is Arg261. Arg261 is located close to the β -phosphate of UDP-N-acetylglucosamine and is proposed to stabilize the leaving group during catalysis (Ha, et al., 2001) . It has been speculated that His371 in human UGTs may have a similar kind of role (Radominska-Pandya, et al., 2005) .
The activity and the kinetic results strongly suggest that, in addition to His371, Glu379 is one of the key residues involved in UDPGA binding (Fig. 8) . Consistent with this, even very distant homologoues of the UGTs use the equivalent Glu to bind the nucleotide. For instance, Glu269 in MurG has been suggested to have a role in discriminating between UDP and dTDP (Hu, et al., 2003) . Similarly, in E.coli T4 bacteriophage β -glucosyltransferase, which catalyses the transfer of glucose from UDP-glucose to hydroxymethylated cytosines, Glu272 makes the equivalent This article has not been copyedited and formatted. The final version may differ from this version. contacts to the ribose moiety (Morera, et al., 1999) . However, in three of the five GT1 structures, UDP-glucosyltransferase GtfB (PDB entry 1IIR), vancosaminyltransferase GtfD (PDB entry 1RRV) and TDP-epi-vancosaminyltransferase GtfA (PDB entries 1PN3, 1PNV), there is a hydrophobic residue in the position equivalent to Glu379. It has been proposed that a hydrophobic residue at this position lowers the affinity of the enzymes for their respective sugar donors (Hu, et al., 2003) . In GtfB and GtfD, the K m values for the nucleotide-sugar donors are 1-2 mM (Mulichak, et al., 2001; Mulichak, et al., 2004) while it is in the micromolar range in MurG (Hu, et al., 2003 ).
The new model, available on request from us, also has predictive power. For example, it suggests that Ser308 is hydrogen-bonded to the β -phosphate group in UDPGA, much like Ser285 in the structure of UGT71G1. Similarly, GtfA, GtfB and GtfD all have serines in this position, Ser230, Ser247, and Ser246 (Mulichak, et al., 2001; Mulichak, et al., 2003; Mulichak, et al., 2004) , while
VvGT has a threonine, Thr280. In MurG Ser192 can make a contact to the β -phosphate of UDP-N-acetylglucosamine; replacing this Ser with Ala affects all the kinetic parameters (Hu, et al., 2003) . The role of this Ser was also examined in UGT71G1, and the Ser Ala mutant was inactive (He, et al., 2006) . The highly conserved residues Asp395 and Qln396 appear to form hydrogen bonds to the sugar moiety of UDPGA (Fig. 8) . The initial results from mutation studies of Asp395 and Qln396 support the model (Radominska-Pandya, Finel, unpublished) . The equivalent residues in VvGT, Asp374 and Qln375, as well as Glu381and Qln382 in UGT71G1 make corresponding contacts and were suggested to play a role in sugar recognition (Offen, et al., 2006) . The mutants D374A of VvGT and E381A of UGT71G1 were catalytically inactive, whereas mutants Q375N and Q375H of VvGT1 exhibited seriously impaired activities (Offen, et al., 2006 ) (Shao, et al., 2005) .
This article has not been copyedited and formatted. The final version may differ from this version. In conclusion, the results of this study suggest that both His371 and Glu379 of UGT1A6 are involved in UDPGA binding, but not as a general base or acid. Our study also identifies other possible UDP-binding residues. The identity of the "real" catalytic residues remains open.
superfamily: recommended nomenclature update based on evolutionary divergence. E=UGT, Agly=aglycone, GA=glucuronic acid. Seven scopoletin (25, 100, 250, 500, 1000, 2000 and 4000 µM) and eight UDPGA concentrations (25, 100, 250, 500, 1000, 2500, 10000, 20000 µM) were used. All the activities were normalized for expression levels. The derived kinetic constants are listed in Table 2C .
This article has not been copyedited and formatted. The final version may differ from this version. VvGT (2C1Z) used in the modelling (Fig. 8) . The original alignment was made by ClustalW and manually modified according to structural information from the Jpred, 3d-pssm and 3d-jigsaw servers. The most conserved areas are highlighted with grey and the mutated residues His371 and Glu379 are bold. The figure was made using GeneDoc. 
